Black Rock Inc. Acadia Pharmaceuticals Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 12,062,213 shares of ACAD stock, worth $206 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,062,213
Previous 11,668,740
3.37%
Holding current value
$206 Million
Previous $216 Million
9.15%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ACAD
# of Institutions
279Shares Held
156MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$732 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$236 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$234 Million3.36% of portfolio
-
State Street Corp Boston, MA5.97MShares$102 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.5MShares$59.8 Million0.05% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.76B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...